Compagnie Lombard Odier SCmA’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.3M Sell
309,351
-13,113
-4% -$2.91M 0.83% 29
2025
Q4
$73.7M Buy
322,464
+16,262
+5% +$3.7M 0.8% 30
2025
Q3
$70.9M Sell
306,202
-3,902
-1% -$795K 0.78% 28
2025
Q2
$57.6M Sell
310,104
-33,055
-10% -$6.14M 0.76% 35
2025
Q1
$71.9M Sell
343,159
-14,741
-4% -$2.87M 0.88% 30
2024
Q4
$63.6M Buy
357,900
+11,491
+3% +$2.11M 0.94% 30
2024
Q3
$68.4M Buy
346,409
+17,699
+5% +$3.3M 1.06% 25
2024
Q2
$56.4M Sell
328,710
-5,514
-2% -$913K 0.95% 28
2024
Q1
$60.9M Buy
334,224
+3,367
+1% +$580K 1.08% 25
2023
Q4
$51.3M Buy
330,857
+23,408
+8% +$3.41M 0.95% 27
2023
Q3
$45.8M Sell
307,449
-7,655
-2% -$1.12M 1.06% 25
2023
Q2
$42.5M Sell
315,104
-36,492
-10% -$5.35M 1.19% 25
2023
Q1
$56M Sell
351,596
-68,023
-16% -$10.4M 1.4% 18
2022
Q4
$67.8M Sell
419,619
-10,473
-2% -$1.61M 1.82% 14
2022
Q3
$57.7M Sell
430,092
-41,232
-9% -$5.92M 1.66% 15
2022
Q2
$72.2M Sell
471,324
-22,428
-5% -$3.43M 1.83% 14
2022
Q1
$80M Sell
493,752
-65,024
-12% -$9.45M 1.69% 16
2021
Q4
$75.7M Sell
558,776
-67,437
-11% -$7.97M 1.5% 22
2021
Q3
$67.6M Sell
626,213
-447,080
-42% -$51.1M 1.46% 22
2021
Q2
$121M Buy
1,073,293
+813
+0.1% +$91.6K 2.66% 8
2021
Q1
$116M Sell
1,072,480
-118,304
-10% -$12.7M 2.56% 8
2020
Q4
$128M Sell
1,190,784
-77,235
-6% -$7.42M 3.28% 8
2020
Q3
$111M Buy
1,268,019
+15,319
+1% +$1.44M 3.31% 9
2020
Q2
$123M Buy
1,252,700
+131,721
+12% +$11.6M 4.13% 6
2020
Q1
$85.4M Sell
1,120,979
-39,159
-3% -$3.34M 3.58% 7
2019
Q4
$103M Sell
1,160,138
-37,549
-3% -$3.12M 3.93% 6
2019
Q3
$90.7M Sell
1,197,687
-238,874
-17% -$16.4M 3.79% 4
2019
Q2
$104M Buy
1,436,561
+249,688
+21% +$19.6M 4.24% 4
2019
Q1
$95.6M Buy
1,186,873
+19,801
+2% +$1.62M 3.95% 4
2018
Q4
$108M Sell
1,167,072
-132,291
-10% -$11.6M 4.41% 2
2018
Q3
$123M Sell
1,299,363
-19,436
-1% -$1.84M 4.3% 3
2018
Q2
$122M Buy
1,318,799
+9,913
+0.8% +$968K 4.49% 2
2018
Q1
$124M Sell
1,308,886
-1,633,548
-56% -$179M 4.51% 2
2017
Q4
$285M Buy
2,942,434
+1,289,833
+78% +$122M 5.11% 2
2017
Q3
$147M Sell
1,652,601
-278,256
-14% -$21.2M 5.21% 2
2017
Q2
$140M Sell
1,930,857
-161,917
-8% -$10.9M 4.85% 2
2017
Q1
$136M Sell
2,092,774
-315,997
-13% -$19.9M 4.61% 2
2016
Q4
$151M Sell
2,408,771
-58,922
-2% -$3.6M 4.41% 2
2016
Q3
$156M Sell
2,467,693
-267,005
-10% -$17.3M 4.54% 2
2016
Q2
$169M Sell
2,734,698
-304,221
-10% -$18.5M 4.92% 2
2016
Q1
$174M Sell
3,038,919
-388,285
-11% -$21.6M 5.31% 2
2015
Q4
$203M Buy
3,427,204
+946,043
+38% +$54.5M 6.38% 2
2015
Q3
$135M Buy
2,481,161
+28,679
+1% +$1.87M 5.5% 2
2015
Q2
$165M Sell
2,452,482
-89,983
-4% -$5.87M 6.12% 1
2015
Q1
$149M Buy
2,542,465
+1,828,735
+256% +$110M 5.6% 1
2014
Q4
$46.7M Buy
713,730
+696,060
+3,939% +$43.9M 2.15% 13
2014
Q3
$1.02M Sell
17,670
-1,406
-7% -$78.1K 0.04% 180
2014
Q2
$1.08M Sell
19,076
-2,340
-11% -$123K 0.04% 184
2014
Q1
$1.1M Hold
21,416
0.05% 185
2013
Q4
$1.13M Buy
+21,416
New +$1.05M 0.05% 188

Other funds holding ABBV

Compagnie Lombard Odier SCmA's ABBV Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA reduced its AbbVie (ABBV) stake by 4.1% in Q1 2026, selling an estimated $2.91M and leaving 309,351 shares worth $67.3M. The position accounts for 0.83% of the portfolio, ranked #29.

Compagnie Lombard Odier SCmA first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $285M in Q4 2017. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Compagnie Lombard Odier SCmA held 309,351 shares of AbbVie worth $67.3M as of Q1 2026.
  • Compagnie Lombard Odier SCmA sold 13,113 AbbVie shares in Q1 2026, an estimated $2.91M.
  • AbbVie made up 0.83% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #29 holding.
  • Compagnie Lombard Odier SCmA first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
  • Compagnie Lombard Odier SCmA's AbbVie position peaked at $285M in Q4 2017.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.